The blood biomarker p-tau217 has "shown the most promise in detecting Alzheimer's in the brain," researchers of a new study say.
WashU researchers have created a model that can seemingly predict a person's symptoms of Alzheimer's within a few years.
Scientists have found a possible explanation for why cancer patients are less likely to develop Alzheimer's.
People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.
New research finds the shingles vaccine can potentially provide broad protection against dementia.
An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.
From tainted baby powder to sketchy blood testing devices, medical scandals are alive and well this century.
Instead of targeting neurons, the researchers specifically sought to repair a critical part of the brain that keeps disease-inducing toxins out.
Harvard researchers have found evidence in mice and human brains that the element lithium could be key to a healthy brain.
Certain parts of the U.S. have noticeably higher rates of dementia than others, a new study of VA healthcare data finds.
New research is the latest to implicate certain viruses as a culprit behind Alzheimer's.
New research looks at the emotional and physical repercussions of having your brain scanned for early signs of dementia.
Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer's.
Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer's.
New research suggests that inhaled xenon gas can help protect the brains of those with Alzheimer's disease.
Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs designed to target Alzheimer's.
Scientists have uncovered a link between having shingles and cognitive decline.
UK scientists have found evidence that liraglutide can reduce brain shrinkage and cognitive decline in Alzheimer's patients.
The test, with an accuracy rate of around 90%, could enable earlier treatment for patients with the disease.
New research finds that people given the Shingrix vaccine were significantly less likely to develop dementia over a six-year-period.
